Lista de obras -

Adrenal insufficiency

artículo científico publicado en 2003

Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma

artículo científico publicado en 2009

Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome

artículo científico publicado en 2003

CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.

artículo científico publicado en 2014

Combination chemotherapy in advanced adrenocortical carcinoma

artículo científico publicado en 2012

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

article

Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome

artículo científico publicado en 2014

DHEA replacement in adrenal insufficiency

artículo científico publicado en 2003

DHEA treatment: myth or reality?

artículo científico publicado en 2002

Deficits in the management of patients with adrenocortical carcinoma in Germany

artículo científico publicado en 2010

Dehydroepiandrosterone and androstenedione

Dehydroepiandrosterone replacement therapy

article published in 2001

Dehydroepiandrosterone supplementation in elderly men: the role of estrogens versus androgens on the male skeleton

artículo científico publicado en 2002

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

artículo científico publicado en 2016

Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock

artículo científico publicado en 2006

Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies

artículo científico publicado en 2009

Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome.

artículo científico publicado en 2010

Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.

artículo científico publicado en 2009

Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency

artículo científico publicado en 2012

Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma

artículo científico publicado en 2014

Gorham-Stout disease--stabilization during bisphosphonate treatment

artículo científico publicado en 2004

High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors

artículo científico publicado en 2010

High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study

artículo científico publicado en 2014

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

artículo científico publicado en 2007

Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens

artículo científico publicado en 2008

Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers

artículo científico publicado en 2010

Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency

artículo científico publicado en 2010

Integrated genomic characterization of adrenocortical carcinoma

artículo científico publicado en 2014

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.

artículo científico publicado en 2015

Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma

artículo científico publicado en 2014

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.

artículo científico publicado en 2012

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.

artículo científico publicado en 2015

Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells

artículo científico publicado en 2015

Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement

scientific article published on 16 November 2012

Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma

artículo científico publicado en 2015

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

artículo científico publicado en 2014

No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies

artículo científico publicado en 2005

Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome

artículo científico publicado en 2015

Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study

artículo científico publicado en 2014

Observational study mortality in treated primary aldosteronism: the German Conn's registry.

artículo científico publicado en 2012

PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.

artículo científico publicado en 2014

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

artículo científico publicado en 2012

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

artículo científico publicado en 2013

Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements

artículo científico publicado en 2006

Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency

artículo científico publicado en 2011

Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging

artículo científico publicado en 2005

Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?

artículo científico publicado en 2013

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

artículo científico publicado en 2013

Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells

artículo científico publicado en 2011

Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial

scientific article published on 26 July 2012

Suspected metastatic adrenocortical carcinoma revealing as pulmonary Kaposi sarcoma in adrenal Cushing's syndrome

artículo científico publicado en 2014

The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism

The role of surgery in the management of recurrent adrenocortical carcinoma

artículo científico publicado en 2012

Timelines in the management of adrenal crisis - targets, limits and reality

scientific article published on 06 November 2014

Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine

artículo científico publicado en 2008

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

artículo científico publicado en 2011

Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.

artículo científico publicado en 2002

β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

artículo científico publicado en 2010

Lista de obras de

Adrenal insufficiency

Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma

Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome

CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.

Combination chemotherapy in advanced adrenocortical carcinoma

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome

DHEA replacement in adrenal insufficiency

DHEA treatment: myth or reality?

Deficits in the management of patients with adrenocortical carcinoma in Germany

Dehydroepiandrosterone and androstenedione

Dehydroepiandrosterone replacement therapy

Dehydroepiandrosterone supplementation in elderly men: the role of estrogens versus androgens on the male skeleton

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock

Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies

Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome.

Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.

Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency

Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma

Gorham-Stout disease--stabilization during bisphosphonate treatment

High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors

High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens

Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers

Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency

Integrated genomic characterization of adrenocortical carcinoma

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.

Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.

Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells

Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement

Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies

Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome

Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study

Observational study mortality in treated primary aldosteronism: the German Conn's registry.

PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements

Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency

Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging

Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells

Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial

Suspected metastatic adrenocortical carcinoma revealing as pulmonary Kaposi sarcoma in adrenal Cushing's syndrome

The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism

The role of surgery in the management of recurrent adrenocortical carcinoma

Timelines in the management of adrenal crisis - targets, limits and reality

Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.

β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma